Catheterization News and Research

RSS

Routine periodic fasting associated with lower hospitalization risk in patients with COVID-19

The main objective of a new prospective observational cohort study was to evaluate whether periodic fasting is linked with severe COVID-19 symptoms.

1 Aug 2022

Study quantifies the cardiovascular risk posed by specific environmental exposures

A new study from the Icahn School of Medicine at Mount Sinai quantifies the cardiovascular risk posed by exposure to specific environmental factors, showing, for example, that air pollution heightens the risk of heart disease mortality by 17 percent.

24 Jun 2022

Environmental factors are highly predictive of people's risk of death, study shows

Along with high blood pressure, diabetes, and smoking, environmental factors such as air pollution are highly predictive of people's chances of dying, especially from heart attack and stroke, a new study shows.

24 Jun 2022

Duke Children's Hospital & Health Center retains No. 1 rank in North Carolina

Duke Children's Hospital & Health Center continues to rank as the No. 1 children's hospital in North Carolina by U.S. News & World Report, with nine pediatric specialties ranked among the best in the nation.

14 Jun 2022

New analysis finds increase in success and efficiency of chronic total occlusion percutaneous coronary intervention

A new analysis of PROGRESS-CTO (PROspective Global REgiStry for the Study of Chronic Total Occlusion Intervention; www.progresscto.org), an international multi-center registry of chronic total occlusion (CTO) percutaneous coronary intervention (PCI), was presented today as late-breaking clinical research at the Society for Cardiovascular Angiography & Interventions (SCAI) 2022 Scientific Sessions.

20 May 2022

Study finds no difference in survival between patients treated with paclitaxel drug-coated devices and non-DCDs

New long-term data from the Safety Assessment of Femoropopliteal Endovascular Treatment With PAclitaxel-coated Devices (SAFE-PAD) study were presented today as late-breaking clinical research at the Society for Cardiovascular Angiography & Interventions (SCAI) 2022 Scientific Sessions.

20 May 2022

Multi-center trial shows promising results for implant-free interatrial shunt device to treat heart failure patients

Results from early clinical evaluation of the Alleviant System to treat heart failure patients with preserved and reduced ejection fraction (HFpEF and HFrEF) was presented today as late-breaking clinical research at the Society for Cardiovascular Angiography & Interventions (SCAI) 2022 Scientific Sessions.

20 May 2022

Clopidogrel monotherapy linked with reduced risk of net adverse clinical events, study finds

Results from a real-world study investigating safety and effectiveness of clopidogrel versus aspirin monotherapy beyond 12 months after PCI in high-risk patients during the chronic maintenance period.

20 May 2022

Study validates long-term safety and efficacy of Harmony transcatheter pulmonary valve implant

A study of one year outcomes in the largest cohort to date of Harmony transcatheter pulmonary valve (TPV) patients with congenital heart disease (CHD) and severe pulmonary regurgitation (PR) was presented today as late-breaking clinical research at the Society for Cardiovascular Angiography & Interventions 2022 Scientific Sessions.

19 May 2022

Disrupt PAD III Trial reveals consistent safety and effectiveness of intravascular lithotripsy

One year outcomes from the Disrupt PAD III Trial comparing intravascular lithotripsy (IVL) with a drug-coated balloon (DCB) to percutaneous transluminal angioplasty (PTA) with a DCB was presented today as late-breaking clinical research at the Society for Cardiovascular Angiography & Interventions 2022 Scientific Sessions.

19 May 2022

Children's Colorado first in the world to implant the newly FDA-approved G-Armor Stent

Children's Hospital Colorado (Children's Colorado) is the first hospital in the world to implant the newly FDA-approved G-Armor Stent. Although the stent is designed to be used in the smallest of patients, it was first implanted in a Colorado father of two.

18 May 2022

Johns Hopkins Children’s Center doctors save a newborn baby with congenital diaphragmatic hernia

Sarah Gonzalez was just 13 weeks pregnant in 2018 when she received "terrifying" news during a routine ultrasound.

19 Apr 2022

Sodium thiosulfate shows no benefits for reducing heart damage following a heart attack

Sodium thiosulfate showed no benefits for reducing injury to damaged areas of heart muscle following a heart attack, in a study presented at the American College of Cardiology's 71st Annual Scientific Session.

5 Apr 2022

Addition of alirocumab to high-intensity statin treatment reduces key measures of plaque vulnerability

Compared with a placebo, the addition of the injectable cholesterol-lowering drug alirocumab to high-intensity statin treatment in patients who have had a heart attack resulted in twofold greater reductions in three key measures of plaque vulnerability that signal risk for future cardiac events, according to research presented at the American College of Cardiology's 71st Annual Scientific Session.

3 Apr 2022

Experimental drug for hypertrophic cardiomyopathy reduces the need for invasive procedures, trial shows

Findings from a Cleveland Clinic-led clinical trial showed that the use of an experimental drug in severely symptomatic, hypertrophic cardiomyopathy patients significantly reduced the need for invasive procedures.

2 Apr 2022

Comprehensive preventive efforts cut the number of catheter infections

Patients with urinary catheters often get infections. But more comprehensive preventive efforts in health care cut the proportion affected in a group of frail elderly patients from 18 to 4 percent, a study led by University of Gothenburg researchers shows.

28 Mar 2022

High prevalence of COVID-19 in myocardial infarction patients undergoing percutaneous coronary intervention

A team of scientists from Iran has recently estimated the prevalence of coronavirus disease 2019 (COVID-19) in myocardial infarction patients receiving a primary percutaneous coronary intervention. A considerably high prevalence of COVID-19 has been observed among study participants. The study is currently available on the Research Square* Preprint Server.

16 Mar 2022

Children's Hospital Los Angeles becomes first in the world to implant cardiac stent in babies

A Children's Hospital Los Angeles team has become the first in the world to implant a cardiac stent that's designed specifically for babies and young children and can be expanded all the way to adult size.

28 Feb 2022

Researchers explore novel strategy to improve the reprogramming efficiency of human fibroblasts

Not too long ago the idea of taking, for instance a skin cell and transforming it into a muscle cell was unthinkable. About 10 years ago, however, revolutionary research showed that it is indeed possible to reprogram differentiated adult cells into other types fully capable of conducting new functions.

6 Jan 2022

Phenome study reveals alternate associations with SARS-CoV-2 risk loci

Researchers from the Duke Molecular Physiology Institute have been investigating genetic associations with more severe disease and examining the associations that certain genetic features have with other diseases.

13 Dec 2021

Catheterization News and Research

Routine periodic fasting associated with lower hospitalization risk in patients with COVID-19

Study quantifies the cardiovascular risk posed by specific environmental exposures

Environmental factors are highly predictive of people's risk of death, study shows

Duke Children's Hospital & Health Center retains No. 1 rank in North Carolina

New analysis finds increase in success and efficiency of chronic total occlusion percutaneous coronary intervention

Study finds no difference in survival between patients treated with paclitaxel drug-coated devices and non-DCDs

Multi-center trial shows promising results for implant-free interatrial shunt device to treat heart failure patients

Clopidogrel monotherapy linked with reduced risk of net adverse clinical events, study finds

Study validates long-term safety and efficacy of Harmony transcatheter pulmonary valve implant

Disrupt PAD III Trial reveals consistent safety and effectiveness of intravascular lithotripsy

Children's Colorado first in the world to implant the newly FDA-approved G-Armor Stent

Johns Hopkins Children’s Center doctors save a newborn baby with congenital diaphragmatic hernia

Sodium thiosulfate shows no benefits for reducing heart damage following a heart attack

Addition of alirocumab to high-intensity statin treatment reduces key measures of plaque vulnerability

Experimental drug for hypertrophic cardiomyopathy reduces the need for invasive procedures, trial shows

Comprehensive preventive efforts cut the number of catheter infections

High prevalence of COVID-19 in myocardial infarction patients undergoing percutaneous coronary intervention

Children's Hospital Los Angeles becomes first in the world to implant cardiac stent in babies

Researchers explore novel strategy to improve the reprogramming efficiency of human fibroblasts

Phenome study reveals alternate associations with SARS-CoV-2 risk loci

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News